Arachidonic acid release and prostaglandin F(2alpha) formation induced by anandamide and capsaicin in PC12 cells.
Anandamide, an endogenous agonist of cannabinoid receptors, activates various signal transduction pathways. Anandamide also activates vanilloid VR(1) receptor, which was a nonselective cation channel with high Ca(2+) permeability and had sensitivity to capsaicin, a pungent principle in hot pepper. The effects of anandamide and capsaicin on arachidonic acid metabolism in neuronal cells have not been well established. We examined the effects of anandamide and capsaicin on arachidonic acid release in rat pheochromocytoma PC12 cells. Both agents stimulated [3H]arachidonic acid release in a concentration-dependent manner from the prelabeled PC12 cells even in the absence of extracellular CaCl(2). The effect of anandamide was neither mimicked by an agonist nor inhibited by an antagonist for cannabinoid receptors. The effects of anandamide and capsaicin were inhibited by phospholipase A(2) inhibitors, but not by an antagonist for vanilloid VR(1) receptor. In PC12 cells preincubated with anandamide or capsaicin, [3H]arachidonic acid release was marked and both agents were no more effective. Co-addition of anandamide or capsaicin synergistically enhanced [3H]arachidonic acid release by mastoparan in the absence of CaCl(2). Anandamide stimulated prostaglandin F(2alpha) formation. These findings suggest that anandamide and capsaicin stimulated arachidonic acid metabolism in cannabinoid receptors- and vanilloid VR(1) receptor-independent manner in PC12 cells. The possible mechanisms are also discussed.
Someya
Akiyoshi
A
Laboratory of Chemical Pharmacology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 263-8522, Japan.
Horie
Syunji
S
Murayama
Toshihiko
T
D000818:Animals; D016718:Arachidonic Acid / Q000378:metabolism*; D001095:Arachidonic Acids / Q000494:pharmacology*; D002122:Calcium Chloride / Q000494:pharmacology; D002211:Capsaicin / Q000494:pharmacology*; D015237:Dinoprost / Q000096:biosynthesis*; D004305:Dose-Response Relationship, Drug; D063388:Endocannabinoids; D020536:Enzyme Activators / Q000494:pharmacology; D005110:Extracellular Space / Q000737:chemistry; D036341:Intercellular Signaling Peptides and Proteins; D015759:Ionomycin / Q000494:pharmacology; D007476:Ionophores / Q000494:pharmacology; D016716:PC12 Cells; D010455:Peptides; D010741:Phospholipases A / Q000037:antagonists & inhibitors / Q000378:metabolism; D053284:Polyunsaturated Alkamides; D051381:Rats; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug / Q000378:metabolism; D014862:Wasp Venoms / Q000494:pharmacology
D001095:Arachidonic Acids; D063388:Endocannabinoids; D020536:Enzyme Activators; D036341:Intercellular Signaling Peptides and Proteins; D007476:Ionophores; D010455:Peptides; D053284:Polyunsaturated Alkamides; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug; D014862:Wasp Venoms; D016718:Arachidonic Acid; D015759:Ionomycin; C037500:mastoparan; D015237:Dinoprost; D010741:Phospholipases A; D002122:Calcium Chloride; D002211:Capsaicin; C078814:anandamide